Natus Medical Incorporated (NTUS)

NASDAQ

Currency in USD

Disclaimer

32.96

0.00(0.00%)

Closed20/07

Fair Value

Day's Range

32.84

33.07

52 wk Range

20.90

33.93

NTUS Income Statement

Featured here, the Income Statement (earnings report) for Natus Medical Incorporated, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

Total Revenues

500.97

530.89

495.18

415.68

473.44

Total Revenues Growth

+31.18%

+5.97%

-6.73%

-16.05%

+13.89%

Cost Of Revenues

213.38

217.95

196.55

179.51

193.52

Gross Profit

287.59

312.94

298.62

236.17

279.92

Gross Profit Growth

+21.21%

+8.81%

-4.57%

-20.91%

+18.53%

Gross Profit Margin %

57.41%

58.95%

60.31%

56.82%

59.13%

Other Operating Expenses, Total

277.96

294.68

269.55

245.88

250.54

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+54.03%	+6.01%	-8.53%	-8.78%	+1.9%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	51.82	61.48	58.73	61.3	58.01
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	200.59	207.28	188.76	156.4	170.67
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

9.63

18.26

29.07

-9.71

29.38

Operating Income Growth

-83.04%

+89.61%

+59.21%

-133.38%

+402.72%

EBIT Margin %

1.92%

3.44%

5.87%

-2.33%

6.21%

Net Interest Expenses

-4.66

-6.46

-4.69

-3.65

-1.79

Net Interest Expenses Growth

-3,948.7%

-38.75%

+27.38%

+22.3%

+51.03%

Interest Expense, Total

-5.08

-6.79

-4.94

-3.66

-1.87

Interest And Investment Income

0.43

0.33

0.25

0.01

0.09

Other Non Operating Expenses, Total

1.09

-1.24

-0.9

1.77

-2.64

EBT, Excl. Unusual Items

6.06

10.56

23.48

-11.58

24.96

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-5.59

-

-6.68

2.1

EBT, Incl. Unusual Items

5.15

-32.26

-21.26

-22.07

19.36

EBT, Incl. Unusual Items Growth

-90.62%

-726.41%

+34.11%

-3.8%

+187.72%

EBT, Incl. Unusual Items Margin

1.03%

-6.08%

-4.29%

-5.31%

4.09%

Income Tax Expense

25.44

-9.33

-5.59

-5.45

6.18

Net Income to Company

-20.29

-22.94

-15.67

-16.61

13.18

Minority Interest

-

-

-

-

-

Net Income

-20.29

-22.94

-15.67

-16.61

13.18

Net Income Growth

-147.64%

-13.02%

+31.67%

-6.01%

+179.32%

Net Income Margin %

-4.05%

-4.32%

-3.16%

-4%

2.78%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-20.29

-22.94

-15.67

-16.61

13.18

Basic EPS - Continuing Operations

-0.62

-0.69

-0.47

-0.49

0.39

Basic EPS - Continuing Operations Growth

-147.49%

-11.15%

+32.86%

-6.43%

+179.06%

Diluted EPS - Continuing Operations

-0.62

-0.69

-0.47

-0.49

0.39

Diluted EPS - Continuing Operations Growth

-148.31%

-11.15%

+32.15%

-5.32%

+178.79%

Basic Weighted Average Shares Outstanding

32.56

33.11

33.7

33.56

33.67

Diluted Weighted Average Shares Outstanding

32.56

33.11

33.7

33.56

33.97

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

37.61

50

58.36

18.17

57.33

EBITDA Growth

-47.47%

+32.94%

+16.71%

-68.86%

+215.53%

EBITDA Margin %

7.51%

9.42%

11.79%

4.37%

12.11%

EBIT